Overall, our findings suggest that the poorly antigenic tumor cells of PDAC are resistant to immune control but deletion of Smad4 increases MHC‐I expression on PDAC cells and promotes antitumor immune response. This evidence concerns the gene SMAD4 and neoplasm.